Report Highlights
Including: 1) By Technology: Ion Semiconductor Sequencing; Pyro-Sequencing; Synthesis Sequencing; Real Time Sequencing; Ligation Sequencing; Reversible Dye Termination Sequencing; Nano-Pore Sequencing
2) By Application: Screening; Companion Diagnostics
3) By End User: Hospital Laboratories; Clinical Research Organizations; Diagnostic laboratories
Covering: Thermo Fisher Scientific(Qiagen); Oxford Nanopore Technologies; QIAGEN; Myriad Genetics; Illumina
Clinical Oncology Next Generation Sequencing Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on clinical oncology next generation sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
- Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description:
Where is the largest and fastest growing market for clinical oncology next generation sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The clinical oncology next generation sequencing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Report Synopsis
| Report Metrics | Details |
| Base year considered | 2022 |
| Forecast period considered | 2022-2032 |
| Units considered | $ Billion |
| Segments covered | By Technology, By Application, By End User |
| Industry covered | Medical Equipment |
| Regions covered | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Countries covered | Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA |
| Companies studied |
|
Scope
Markets Covered:
- By Technology: Ion Semiconductor Sequencing; Pyro-Sequencing; Synthesis Sequencing; Real Time Sequencing; Ligation Sequencing; Reversible Dye Termination Sequencing; Nano-Pore Sequencing
- By Application: Screening; Companion Diagnostics; Other Diagnostics
- By End User: Hospital Laboratories; Clinical Research Organizations; Diagnostic laboratories
Companies Mentioned: Thermo Fisher Scientific(Qiagen); Oxford Nanopore Technologies; QIAGEN; Myriad Genetics; Illumina
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
- Table 1 : Global Historic Market Growth, 2017-2022, $ Billion
- Table 2 : Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
- Table 3 : Global Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 4 : Global Clinical Oncology Next Generation Sequencing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 5 : Global Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 6 : Global Clinical Oncology Next Generation Sequencing Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 7 : Global Clinical Oncology Next Generation Sequencing Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 8 : Asia-Pacific, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 9 : Asia-Pacific, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 10 : China, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 11 : China, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 12 : India, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 13 : India, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 14 : Japan, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 15 : Japan, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 16 : Australia, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 17 : Australia, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 18 : Indonesia, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 19 : Indonesia, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 20 : South Korea, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 21 : South Korea, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 22 : Western Europe, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 23 : Western Europe, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 24 : UK, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 25 : UK, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 26 : Germany, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 27 : Germany, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 28 : France, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 29 : France, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 30 : Eastern Europe, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 31 : Eastern Europe, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 32 : Russia, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 33 : Russia, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 34 : North America, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 35 : North America, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 36 : USA, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 37 : USA, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 38 : South America, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 39 : South America, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 40 : Brazil, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 41 : Brazil, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 42 : Middle East, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 43 : Middle East, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 44 : Africa, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 45 : Africa, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 46 : Thermo Fisher Scientific(Qiagen) Financial Performance
- Table 47 : Oxford Nanopore Technologies Financial Performance
- Table 48 : QIAGEN Financial Performance
- Table 49 : Myriad Genetics Financial Performance
- Table 50 : Illumina Financial Performance
- Figure 1 : Global Historic Market Growth, 2017-2022, $ Billion
- Figure 2 : Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
- Figure 3 : Global Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 4 : Global Clinical Oncology Next Generation Sequencing Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 5 : Global Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 6 : Global Clinical Oncology Next Generation Sequencing Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 7 : Global Clinical Oncology Next Generation Sequencing Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 8 : Asia-Pacific, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 9 : Asia-Pacific, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 10 : China, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 11 : China, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 12 : India, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 13 : India, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 14 : Japan, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 15 : Japan, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 16 : Australia, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 17 : Australia, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 18 : Indonesia, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 19 : Indonesia, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 20 : South Korea, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 21 : South Korea, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 22 : Western Europe, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 23 : Western Europe, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 24 : UK, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 25 : UK, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 26 : Germany, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 27 : Germany, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 28 : France, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 29 : France, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 30 : Eastern Europe, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 31 : Eastern Europe, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 32 : Russia, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 33 : Russia, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 34 : North America, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 35 : North America, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 36 : USA, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 37 : USA, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 38 : South America, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 39 : South America, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 40 : Brazil, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 41 : Brazil, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 42 : Middle East, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 43 : Middle East, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 44 : Africa, Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 45 : Africa, Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 46 : Thermo Fisher Scientific(Qiagen) Financial Performance
- Figure 47 : Oxford Nanopore Technologies Financial Performance
- Figure 48 : QIAGEN Financial Performance
- Figure 49 : Myriad Genetics Financial Performance
- Figure 50 : Illumina Financial Performance
The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.
Similar Reports from TBRC (Publisher)
Clinical Oncology Next Generation Sequencing Global Market Report 2022
Including: 1) By Technology: Ion Semiconductor Sequencing; Pyro-Sequencing; Synthesis Sequencing; Real Time Sequencing; Ligation Sequencing; Reversible Dye Termination Sequencing; Nano-Pore Sequencing
2) By Application: Screening; Companion Diagnostics; Other Diagnostics
3) By End User: Hospital Laboratories; Clinical Research Organizations; Diagnostic laboratories
Covering: Thermo Fisher Scientific(Qiagen); Oxford Nanopore Technologies; QIAGEN; Myriad Genetics; Illumina; F. Hoffmann-La Roche
Clinical Oncology Next Generation Sequencing Global ...
Clinical Oncology Next Generation Sequencing Global Market Report 2021: COVID-19 Growth And Change To 2030
Including: 1) By Technology: Ion Semiconductor Sequencing; Pyro-Sequencing; Synthesis Sequencing; Real Time Sequencing; Ligation Sequencing; Reversible Dye Termination Sequencing; Nano-Pore Sequencing
2) By Application: Screening; Companion Diagnostics; Other Diagnostics
3) By End User: Hospital Laboratories; Clinical Research Organizations; Diagnostic laboratories
Covering: Thermo Fisher Scientific(Qiagen); Oxford Nanopore Technologies; QIAGEN; Myriad Genetics; Illumina
Clinical Oncology Next Generation Sequencing Global Market Report 2021: ...
Clinical Oncology Next Generation Sequencing Global Market Report 2020-30: COVID 19 Growth and Change
Including: 1) By Technology: Ion Semiconductor Sequencing; Pyro-Sequencing; Synthesis Sequencing; Real Time Sequencing; Ligation Sequencing; Reversible Dye Termination Sequencing; Nano-Pore Sequencing
2) By Application: Screening; Companion Diagnostics; Other Diagnostics
3) By End User: Hospital Laboratories; Clinical Research Oraganizations; Diagnostic laboratories
Covering: Thermo Fisher Scientific(Qiagen); Oxford Nanopore Technologies; QIAGEN; Myriad Genetics; Illumina
Clinical Oncology Next Generation Sequencing Market Global Report 2020-30: ...
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More